Health Care & Life Sciences » Pharmaceuticals | Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp. | Mutual Funds

Mutual Funds that own Tonix Pharmaceuticals Holding Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Vanguard Total Stock Market Index Fund
130,509
1.37%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
78,419
0.82%
6,500
0%
07/31/2018
38,000
0.4%
38,000
0.24%
06/30/2017
Fidelity Spartan Extended Market Index Fund
36,997
0.39%
0
0%
07/31/2018
Vanguard Institutional Total Stock Market Index Fund
19,016
0.2%
0
0%
07/31/2018
DFA US Targeted Value Portfolio
13,635
0.14%
0
0%
04/30/2018
DFA US Micro Cap Portfolio
9,821
0.1%
0
0%
04/30/2018
DFA Tax Managed US Targeted Value Portfolio
6,101
0.06%
0
0%
04/30/2018
DFA US Core Equity 2 Portfolio
6,057
0.06%
0
0%
04/30/2018
2,437
0.03%
0
0.01%
09/05/2018

About Tonix Pharmaceuticals Holding

View Profile
Address
509 Madison Avenue
New York New York 10022
United States
Employees -
Website http://www.tonixpharma.com
Updated 07/08/2019
Tonix Pharmaceuticals Holding Corp. operates as a clinical-stage pharmaceutical company, which engages in the development of pharmaceutical products for public health challenges. It focuses on delivering an efficacious, and safe long-term treatment for posttraumatic stress disorder. It offers TNX-102 SL, TNX-601, TNX-801, TNX-301, and TNX-701.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.